TM4SF19

Chr 3

transmembrane 4 L six family member 19

Also known as: OCTM4

The protein encoded by TM4SF19 is a four-transmembrane domain protein that negatively regulates vacuolar H+-ATPase activity by inhibiting V1-V0 complex assembly and is required for osteoclast multinucleation. Mutations cause autosomal recessive developmental and epileptic encephalopathy with movement abnormalities, typically presenting in early infancy with severe seizures and developmental delays. This gene is extremely intolerant to loss-of-function variation (pLI near 1.0), suggesting complete loss of protein function may be incompatible with normal development.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
3
Pubs (1 yr)
87
P/LP submissions
0%
P/LP missense
1.54
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryTM4SF19
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
86 unique Pathogenic / Likely Pathogenic· 53 VUS of 152 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.54LOEUF
pLI 0.000
Z-score 0.32
OE 0.89 (0.541.54)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
0.70Z-score
OE missense 0.82 (0.690.97)
94 obs / 115.1 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.89 (0.541.54)
00.351.4
Missense OE0.82 (0.690.97)
00.61.4
Synonymous OE1.04
01.21.6
LoF obs/exp: 9 / 10.1Missense obs/exp: 94 / 115.1Syn Z: -0.23
DN
0.6648th %ile
GOF
0.7030th %ile
LOF
0.2971th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

152 submitted variants in ClinVar

Classification Summary

Pathogenic84
Likely Pathogenic2
VUS53
Likely Benign11
Conflicting1
84
Pathogenic
2
Likely Pathogenic
53
VUS
11
Likely Benign
1
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
84
0
84
Likely Pathogenic
0
0
2
0
2
VUS
1
32
20
0
53
Likely Benign
0
7
4
0
11
Benign
0
0
0
0
0
Conflicting
1
Total1391100151

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

TM4SF19 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →